In addition to all topics pertaining to women’s cancer, we encourage innovative ideas focusing on six key areas, as outlined below. Novel approaches do not need significant sample sizes resembling clinical trial design; rather, they can showcase innovative ways to advance science in gynecologic oncology to ultimately eradicate women’s cancer.

1. Development of Clinical Trials and the Evolution of Clinical Studies - Novel endpoints specific to clinical trials, Phase II/III trials, evolution of trial design and new scientific approaches to clinical trials

2. Novel Surgical Techniques - Looking beyond what exists today to the next wave of surgical innovation

3. Quality of Life/Survivorship - Approaches to QOL and survivorship in your institution/practice and novel program planning and implementation

4. Health Care Reform and Health Care Outcomes - Topics on cost effectiveness, quality outcomes and quality measures

5. Serous Tubal Intraepithelial Carcinoma - Updates on fallopian tube carcinogenesis and its role in the future management and prevention of high-grade serous carcinomas

6. Palliative Care - Innovative and novel approaches to palliative medicine and its use in treatment throughout the course of disease

In addition to the key concepts, contributors are encouraged to submit research in any of the following categories:

• Breast Cancer
• Cervical Cancer
• Chemotherapy
• Clinical Practice Issues
• Clinical Trials - Phase I
• Clinical Trials - Ovary/Fallopian Tube/Primary Peritoneal Cancer/Breast, Phase II/III
• Clinical Trials - Cervix Phase II/III
• Clinical Trials - Uterine Cancer/Endometrial/Sarcoma, Phase II/III
• Uterine/Endometrial Cancer
• Public Health/Epidemiology
• Hereditary Cancers and the Role of Genetics
• Ovarian/Fallopian Tube/Primary Peritoneal Cancer
• Surgical Techniques/Robotics/Minimally Invasive Surgery
• Supportive Care
• Quality of Life
• Gestational Trophoblastic Disease/Vulvar and Vaginal Cancers/Rare Tumors/Sarcomas
• Surgical Films
• Translational Research/Basic Science